SAM
Sectoral Asset Management Portfolio holdings
AUM
$162M
1-Year Est. Return
44.84%
1 Year Est. Return
+44.84%
AUM
$151M
AUM Growth
+$23M
(+18%)
Holding
109
Top Buys
| 1 | +$2.19M | |
| 2 | +$2.16M | |
| 3 | +$2.15M | |
| 4 |
Oric Pharmaceuticals
ORIC
|
+$2.15M |
| 5 |
Solid Biosciences
SLDB
|
+$2.05M |
Top Sells
| 1 | +$2.14M | |
| 2 | +$1.37M | |
| 3 | +$1.21M | |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$1.12M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
+$994K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
enGene Holdings
ENGN
$437M
| – | – |
-11,700
|
|
||
102
Icon
ICLR
$12.4B
| – | – |
-4,000
|
|
||
103
Medtronic
MDT
$123B
| – | – |
-23,850
|
|
||
104
Novo Nordisk
NVO
$214B
| – | – |
-2,850
|
|
||
105
Phreesia
PHR
$1.3B
| – | – |
-34,000
|
|
||
106
Rocket Pharmaceuticals
RCKT
$330M
| – | – |
-44,383
|
|
||
107
iShares 0-3 Month Treasury Bond ETF
SGOV
$57.6B
| – | – |
-3,589
|
|
||
|
SWTX
108
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-25,325
|
|
||
109
Tenet Healthcare
THC
$17B
| – | – |
-9,000
|
|